Perjeta, also known as pertuzumab, is a significant advancement in addressing HER2-positive mammary cancer. This drug works by inhibiting a specific pathway that helps cancer cells grow . Differing from some alternative HER2-targeted therapies, pertuzumab doesn’t directly block the HER2 receptor … Read More